Ligand validation:8P90

DXC: (3ALPHA,5BETA,12ALPHA)-3,12-DIHYDROXYCHOLAN-24-OIC ACID

DXC is a Ligand Of Interest in 8P90 designated by the Author

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
8P90_DXC_B_606	39%	59%	0.241	0.949	0.57	0.99	-	1	0	0	100%	1
8P90_DXC_A_405	32%	39%	0.252	0.927	0.71	1.63	1	10	3	0	100%	1
8P90_DXC_A_404	25%	61%	0.302	0.943	0.63	0.87	1	2	2	0	100%	1
8P90_DXC_B_602	21%	43%	0.319	0.931	0.68	1.52	-	9	4	0	100%	0.5
8P90_DXC_B_601	18%	40%	0.316	0.904	0.63	1.69	1	11	1	0	100%	1
8P90_DXC_A_407	16%	51%	0.385	0.963	0.61	1.27	-	4	1	0	100%	1
8P90_DXC_B_607	13%	48%	0.376	0.925	0.71	1.29	-	6	2	0	100%	1
8P90_DXC_B_608	7%	53%	0.352	0.803	0.67	1.15	-	4	2	0	100%	1
8P90_DXC_A_406	6%	46%	0.413	0.849	0.66	1.39	-	5	3	0	100%	0.5
8P90_DXC_A_408	4%	43%	0.389	0.777	0.61	1.55	-	8	3	0	100%	1
4QN9_DXC_A_505	57%	41%	0.186	0.964	0.97	1.32	1	6	2	0	100%	1
8PC4_DXC_A_408	44%	59%	0.215	0.945	0.53	1.04	-	1	1	0	100%	1
8P96_DXC_B_601	43%	62%	0.232	0.956	0.57	0.86	-	-	1	0	100%	1
6UAD_DXC_A_201	92%	20%	0.067	0.959	1.54	1.82	5	12	0	0	100%	1
4A83_DXC_A_1161	90%	60%	0.068	0.95	0.69	0.83	-	1	4	0	100%	1
1OS6_DXC_A_75	84%	17%	0.079	0.939	2.14	1.51	13	9	2	0	100%	1
4HAJ_DXC_A_75	81%	47%	0.1	0.952	0.97	1.08	1	4	2	0	100%	1
3O01_DXC_B_1	75%	44%	0.098	0.929	0.76	1.39	-	6	0	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.